does tirzepatide have cardiovascular benefits effects of Potential mechanisms by which tirzepatide

Patients should use the same arm, same time, same position at each measurement

In agreement with expectations, the first outcome trial of a GLP-1RA, the ELIXA trial of the short-acting lixisenatide, an exendin-4 derivative with properties almost identical to those of exendin-4 or exenatide (stable, full agonists of the GLP-1 receptor), showed no increased cardiovascular risk in a patient group with severely increased CVD risk

8,9 GLP-1 agonists also upregulate keratinocyte migration due to P13K/Akt activation, which is pertinent to wound healing

It kills two birds with one stone with priming and sun protection, as well as providing pollution defence to further halt skin stressors that can cause breakouts